Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
SOMERSET, N.J., March 31, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced it’s providing its leading e-prescribing solution free of charge for a limited period of time to physicians who have yet to implement an e-prescribing solution in the wake of New York’s new e-prescribing mandate.
“As of this week, New York’s I-STOP law took effect for all New York physicians and pharmacists,” said Amritpal Deol, MTBC General Counsel. She added, “I-STOP, which marks the beginning of a national trend, requires that all prescriptions be issued electronically, thereby rendering the paper prescription pad a relic of a bygone era.”
As part of MTBC’s I-STOP promotion, New York physicians who signup for MTBC’s e-prescribing by May 1, 2016, are entitled to use MTBC eRx free of charge for one year. This promotional offer is limited to 5 physicians per practice and only available to the first 500 physicians who contact MTBC.
MTBC eRx, MTBC’s proprietary electronic prescribing solution, is fully integrated with PracticeProTM, which includes a certified web-based EHR, practice management and revenue cycle management system. MTBC’s proprietary e-prescribing solution is available as an app, MTBC iRx, for Apple and Android users and an app for Apple Watch.
All of MTBC e-prescribe solutions are Surescripts® White Coat certified and facilitate controlled substances electronic prescribing through integration with EPCS Gold 2.0 by DrFirst®.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC [email protected] (732) 873-5133 x 141
